ASML's Bull Case Before Q2 2026 Earnings: Analyst Targets, AI Demand, and the Key Risks to Watch

RBC Capital — Outperform, target raised to $2,000 (July 14, 2026)

One day before the earnings report, RBC Capital raised its price target to $2,000 from $1,700, maintaining an Outperform rating . RBC noted that EUV demand trends have improved since ASML's last earnings report, though cautioned that near-term upside is likely modest given long lead times . The analyst cited robust GenAI investments, DRAM tightness, and intensifying competition at leading-edge foundries as key drivers .

Other notable moves:

• Morgan Stanley analyst Lee Simpson raised the firm's price target to EUR 1,830 from EUR 1,660 in early July .
• Bank of America named ASML a top European semiconductor pick for 2026 earlier in the year .

Q1 2026 Earnings Beat & Raised Guidance

ASML's Q1 2026 results, reported on April 15, 2026, provided the fundamental basis for the current optimism:

• Revenue: €8.8 billion (+13% YoY), beating consensus estimates of roughly €8.6 billion .
• EPS: €7.15 (+19% YoY), beating the Zacks Consensus Estimate by 8.4% .
• Gross margin: 53.0%, at the very top of guidance .
• Net income: €2.8 billion .

The company raised its full-year 2026 revenue guidance to between €36 billion and €40 billion, up from the prior range of €34–€39 billion . CEO Christophe Fouquet stated, "Chip demand is outpacing supply," and noted that customers are accelerating capacity expansion plans for 2026 and beyond .

EUV system sales alone contributed €4.1 billion in Q1, including revenue from two high-NA EUV systems .

A notable nuance: ASML's Q2 2026 revenue guidance was softer (€8.4B–€9.0B at the midpoint of €8.7B, versus consensus around €9.1B), which caused the stock to dip 6% on the Q1 release day despite the beat . The stock has since recovered and gained roughly 22–25% from the post-Q1 low.

Stock Performance: 67% YTD and a $45 Billion Backlog

The market narrative has undergone a sharp reversal from mid-2025, when fears over U.S.-China tariffs and export restrictions weighed heavily on the stock . That has flipped entirely to an AI-infrastructure-driven supply-demand imbalance for ASML's extreme ultraviolet (EUV) lithography systems.

Key performance figures:

• Year-to-date gain: ASML shares are up approximately 67% in 2026, per Reuters . Other sources cite 50–53% , but the 67% figure is broadly consistent with the most recent Reuters report from July 14.
• 12-month return: ASML has more than doubled (+120%) over the past 12 months .
• Backlog: The company is sitting on an unprecedented order backlog of roughly $45 billion .
• Capacity: ASML's production capacity may be fully booked through the end of 2027 .

The Average Analyst Target: Wide Dispersion of Views

Consensus price targets vary significantly across aggregators:

The figure of $1,854 from 32 analysts cited in some discussions is verified: MarketBeat reports a consensus price target of $1,854.13 based on 32 analysts, with a rating of "Moderate Buy" . The consensus range is roughly $1,775–$1,985, which sits well below Bernstein's aggressive $2,623 target, reflecting the wide dispersion of views on how quickly ASML can scale EUV output.

Market Narrative: From Tariff Fears to an EUV Supply Crunch

The bull case for ASML rests on a single structural factor: ASML is the sole manufacturer of extreme ultraviolet (EUV) lithography machines, which are essential for producing the most advanced AI chips . There is no competitive alternative.

In early 2025, fears over U.S.-China export restrictions and tariff escalation dominated the narrative . By mid-2026, that narrative has flipped as AI infrastructure spending from hyperscale data-center operators has overwhelmed those concerns. The result is a capacity crunch that ASML's own CEO described as demand "outpacing supply" .

The AI boom is driving capacity expansion in both advanced logic (e.g., TSMC, Intel, Samsung) and memory (DRAM for high-bandwidth memory used in AI accelerators), directly benefiting ASML's monopoly position .

Risks and Debates: Valuation and Geopolitics

Valuation concerns: ASML trades at a trailing P/E of roughly 62 . Several analysts flag this as elevated even relative to the company's strong growth prospects . As Reuters noted in a July 14 preview, ASML needs to "justify its chunky valuation" and demonstrate how it will contend with U.S. moves to block exports to China .

Geopolitical risk: Export restrictions on China sales remain the primary downside factor cited by analysts . A proposed U.S. law would require allies to align with export controls to curb China's ability to make advanced chips, and ASML is explicitly named in the legislation . ASML warned on its Q1 call that tighter export curbs could cloud the outlook . China-related revenues have already declined as a proportion of total sales .

Stock split speculation: No credible or recent source found in the search results confirms or discusses a potential ASML stock split. This appears to be unsupported market chatter not yet covered by major financial news outlets.

The Bottom Line

ASML enters its Q2 2026 earnings report with a powerful trifecta: aggressive analyst upgrades (Bernstein at $2,623, RBC at $2,000), strong operational momentum (€8.8B Q1 beat, raised guidance to €36–€40B), and a structural AI-driven tailwind that has its EUV capacity booked through 2027. The consensus target of roughly $1,854–$1,985 suggests moderate upside from current levels, while the bull case implies significantly more if ASML can deliver on its capacity expansion.

The key questions for the July 15 earnings call: Can ASML deliver Q2 results in line with or above the soft guidance range? Will management update the 2026 guidance higher? And how will they address the dual risks of valuation and export restrictions? The answers will determine whether the 67% YTD rally has further to run or whether the stock needs to consolidate.